Bantigue, Retchelyn A.
HRN: 21-36-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2022
CEFUROXIME 1.5GM (VIAL)
06/10/2022
06/16/2022
IV
1.5
Q8H
Prophylaxis For OR
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes